This synergy was driven by tissue-resident memory T (T<sub>RM</sub>) cell enrichment in the tumor microenvironment (TME), which reached 15.2% in CD4<sup>+</sup> T cells and 12.9% in CD8<sup>+</sup> T cells. This evidence concerns the gene CD8A and neoplasm.